ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...

A father-of-three who had cancerous breast tissue removed said he feels "complete" again after getting a realistic "3D" ...

IBC is a rare, aggressive breast cancer with higher rates in younger women and those of African descent, requiring a ...

Pfizer and Arvinas' experimental breast cancer treatment failed to delay the progression of the disease in a broader group of ...

Antibody treatment which activates the patient's own immune system against cancer, known as immunotherapy, is increasingly ...

An experimental breast cancer treatment co-developed by Pfizer and Arvinas significantly improved the time some patients ...

Women with breast cancer who receive chemotherapy experienced a lasting decline in physical health, a new study found.

Breast cancer is the second leading cause of cancer deaths in women in the U.S., killing more than 42,000 last year ...

The first patients have been enrolled in the HEROES trial, exploring de-escalation of anti-HER2 therapy in metastatic HER2+ ...

About a quarter of Iowans would no longer pay co-pays and deductibles for supplemental and diagnostic breast exams under ...

Individuals with transportation insecurity appeared 41% less likely to undergo breast cancer screening than those without transportation difficulties, according to results of a cohort study. Alexa L.

John Mulaney detailed the risk assessment test that helped his wife Oliva Munn discover her breast cancer diagnosis in 2023.